Methyl iodide → 2-(2-chloro-9-methyl-6-morpholino-9H-purin-8-yl)propan-2-ol

HRID 2093409Notes

Reaction equation

[Cl:1][C:2]1[N:10]=[C:9]2[C:5]([N:6]=[C:7]([C:11]([OH:14])([CH3:13])[CH3:12])[NH:8]2)=[C:4]([N:15]2[CH2:20][CH2:19][O:18][CH2:17][CH2:16]2)[N:3]=1.I[CH3:22]>>[Cl:1][C:2]1[N:10]=[C:9]2[C:5]([N:6]=[C:7]([C:11]([OH:14])([CH3:13])[CH3:12])[N:8]2[CH3:22])=[C:4]([N:15]2[CH2:16][CH2:17][O:18][CH2:19][CH2:20]2)[N:3]=1

Participants

Reactant 2

HCID 6328Methyl iodide

HCID 178458928HCID 178458928, compound

Product 1

HCID 580152132-(2-chloro-9-methyl-6-morpholino-9H-purin-8-yl)propan-2-ol

Procedure

2-(2-Chloro-6-morpholino-9H-purin-8-yl)propan-2-ol (100 mg) was treated with iodomethane via General Procedure C to give crude intermediate 2-(2-chloro-9-methyl-6-morpholino-9H-purin-8-yl)propan-2-ol which was treated with 2-aminopyrimidine-5-boronic acid, pinacol ester via General Procedure A and purified via reverse phase HPLC to give 44 mg of 130 as a white solid. MS (Q1) 371.2 (M)+.

Sources & evidence

ORD record: ord-95e6472ac8bb4d4cb67e86c46a4c30c4
Source dataset: uspto-grants-2013_05
DOI: 10.6084/m9.figshare.5104873.v1
Patent number: US08445487B2

Reaction notes

Loading…